ADAM10 and head and neck cancer: Of the 15 tumor‐suppressor gene targets identified, major hits shown to cooperate with known head and neck cancer driver mutations (PIK3CA, HRAS, TP53, and HPV16‐E6/7) were ADAM10, AJUBA and downstream target of NOTCH, RIPK4, followed by NOTCH2 and NOTCH3.